Crossmark

COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran

Crossref DOI link: https://doi.org/10.1007/s11046-023-00785-3

Published Online: 2023-09-06

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abdorahimi, Mahsa

Pakdel, Farzad

Salehi, Mohammadreza

Alcazar-Fuoli, Laura

Hashemi, Seyed Jamal

Daie Ghazvini, Roshanak

Ahmadkhani, Fardin

Ahmadikia, Kazem

Abdollahi, Alireza

Debran, Juan Carlos Soto

Tabari, Azin

Farrokh, Fatemeh

Mousavand, Atefeh

Afarinesh Khaki, Pegah

Salami Khaneshan, Arezoo

Ibrahim, Ashraf S.

Khodavaisy, Sadegh
Funding

Funding for this research was provided by:

Tehran University of Medical Sciences (1401-1-99-57426)
License Information

Text and Data Mining valid from 2023-09-06

Version of Record valid from 2023-09-06
More Information

Article History

Received: 15 April 2023

Accepted: 10 August 2023

First Online: 6 September 2023

Declarations

:

: The authors have no conflicts of interest to declare that are relevant to the content of this article.

: Each of the authors has read and concurs with the content in the final manuscript. The contents of this manuscript have not been copyrighted or published previously and not now under consideration for publication elsewhere. We have read and understood your journal policies. There are no conflicts of interest to declare.

Document is current

Any future updates will be listed below